题目内容

Every newborn baby is dealt a hand of cards which help to determine how long he or she will be allowed to play the game of life. Good cards will help those who have them to have a long and healthy existence, while bad cards will bring to those who have them terrible diseases like high blood pressure and heart disease. Occasionally, cards are dealt out that doom their holders to an early death. In the past, people never knew exactly which cards they had been dealt. They could guess at the future only by looking at the kind of health problems experienced by their parents or grandparents. Genetic testing, which makes it possible to find dangerous genes, has changed all this. But, until recently, if you were tested positive for a bad gene you were not obliged to reveal this to anyone else except in a few extreme circumstances. This month, however, Britain became the first country in the world to allow life insurers to ask for test results. So far, approval has been given only for a test for a fatal brain disorder known as Huntington"s disease. But ten other tests (for seven diseases) are already in use and are awaiting similar approval. The independent body that gives approval, the Department of Health"s genetics and insurance committee, does not have to decide whether the use of genetic information in insurance is ethical. It must judge only whether the tests are reliable to insurers. In the case of Huntington"s disease the answer is clear-cut. People unlucky enough to have this gene will die early, and cost life insurers dearly. This is only the start. Clear-cut genetic answers, where a gene is simply and directly related to a person"s risk of death, are uncommon. More usually, a group of genes is associated with the risk of developing a common disease, dependent on the presence of other genetic or environmental factors. But, as tests improve, it will become possible to predict whether or not a particular individual is at risk. In the next few years researchers will discover more and more about the functions of individual genes and what health risks — or benefits — are associated with them. The function of genetic testing is

A. to enable people to change genes.
B. to help people to create good genes.
C. to predict diseases people may have.
D. to detect accurately what diseases people may develop.

查看答案
更多问题

在下属哪些情况,一项外观设计专利权可能因为“与在先权利相冲突”而被宣告无效

A. 该外观设计中的图案采用的是他人30年前所画但未发表的一幅水彩画
B. 该外观设计中使用的图片是专利权人自己拍摄的,但由于角度一致,与他人的摄影作品雷同
C. 该外观设计中使用的图形是专利权人自己设计的,并曾经许可他人申请了商标注册,但该商标注册已经被撤销
D. 使用该外观设计的产品在专利申请日前2年就已经有厂家大批量生产销售了

在进行外观设计相同或者实质相同判断时,下列哪些说法是正确的

A. 一般应当用一项在先设计与被比设计进行单独对比
B. 只需将两项外观设计的主要部分进行对比
C. 可以借助放大镜、显微镜、化学手段对外观设计进行观察
D. 仅以产品的外观作为判断的对象

2009年下半年XX市有关部门在全市抽查了6座新建的高档写字楼,这些外表富丽豪华、内部装修典雅的写字楼甲醛超标率达42.11%。请分析产生此现象的原因。

Every newborn baby is dealt a hand of cards which help to determine how long he or she will be allowed to play the game of life. Good cards will help those who have them to have a long and healthy existence, while bad cards will bring to those who have them terrible diseases like high blood pressure and heart disease. Occasionally, cards are dealt out that doom their holders to an early death. In the past, people never knew exactly which cards they had been dealt. They could guess at the future only by looking at the kind of health problems experienced by their parents or grandparents. Genetic testing, which makes it possible to find dangerous genes, has changed all this. But, until recently, if you were tested positive for a bad gene you were not obliged to reveal this to anyone else except in a few extreme circumstances. This month, however, Britain became the first country in the world to allow life insurers to ask for test results. So far, approval has been given only for a test for a fatal brain disorder known as Huntington"s disease. But ten other tests (for seven diseases) are already in use and are awaiting similar approval. The independent body that gives approval, the Department of Health"s genetics and insurance committee, does not have to decide whether the use of genetic information in insurance is ethical. It must judge only whether the tests are reliable to insurers. In the case of Huntington"s disease the answer is clear-cut. People unlucky enough to have this gene will die early, and cost life insurers dearly. This is only the start. Clear-cut genetic answers, where a gene is simply and directly related to a person"s risk of death, are uncommon. More usually, a group of genes is associated with the risk of developing a common disease, dependent on the presence of other genetic or environmental factors. But, as tests improve, it will become possible to predict whether or not a particular individual is at risk. In the next few years researchers will discover more and more about the functions of individual genes and what health risks — or benefits — are associated with them. Health authorities allow insurers to use genetic information for the purpose of

A. improving genetic testing technology.
B. safeguarding patients" interests.
C. promoting disease prevention.
D. reducing insurance payments.

答案查题题库